|
Status |
Public on Aug 29, 2016 |
Title |
B1_Jurkat_DMSO_1 |
Sample type |
RNA |
|
|
Source name |
Jurkat T-ALL
|
Organism |
Homo sapiens |
Characteristics |
cell line: Jurkat genotype: wildtype treatment: Cells were treated with 0.1% DMSO for 6 hours
|
Treatment protocol |
Jurkat cells were plated at 500,000 cells/ mL and incubated in media containing THZ531, THZ532, or THZ531R at the indicated concentrations or with DMSO for 6hrs. At the end of the experiment cells were collected by centrifugation and cell numbers were determined by manually counting cells using C-Chip disposable hemocytometers (Digital Bio, DHC-N01). 5,000,000 cells were isolated from each treatment condition.
|
Growth protocol |
Jurkat cells were grown in RPMI medium supplemented with 1% glutamine and 10% FBS. Cells were cultured at 37 degrees C in a humidified chamber in the presence of 5% CO2, unless otherwise noted.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA from biological replicates (equivalent to 5 million cells per replicate) was subsequently isolated using RNeasy Plus Mini kit (Qiagen, cat#74134) following the manufacturer’s instructions and re-suspended in 50 μL nuclease-free water (Ambion, AM9938). Total RNA was spiked-in with ERCC RNA Spike-In Mix (Ambion, 4456740) and analyzed on Agilent 2100 Bioanalyzer for integrity.
|
Label |
biotin
|
Label protocol |
For microarray analysis, 100 ng of total RNA containing ERCC RNA Spike-In Mix (see above) was used to prepare biotinylated aRNA (cRNA) according to the manufacturer’s protocol (30 IVT Express Kit, Affymetrix 901228). Briefly, total RNA undergoes T7 oligo(dT)-primed reverse transcription to synthesize first-strand cDNA containing a T7 promoter sequence. This cDNA is then converted into a double-stranded DNA template for transcription using DNA Polymerase and RNase H to simultaneously degrade the RNA and synthesize second strand cDNA. In vitro transcription synthesizes aRNA and incorporates a biotin-conjugated nucleotide. The aRNA is then purified to remove unincorporated NTPs, salts, enzymes, and inorganic phosphate. Fragmentation of the biotin-labeled aRNA prepares the sample for hybridization onto GeneChip 3’ expression arrays.
|
|
|
Hybridization protocol |
Samples were prepared for hybridization using 10 µg of biotinylated aRNA in a 1X hybridization cocktail according the Affymetrix hybridization manual. Additional hybridization cocktail components were provided in the Affymetrix GeneChip Hybridization, Wash and Stain Kit. GeneChip arrays (Human PrimeView, Affymetrix 901837) were hybridized in a GeneChip Hybridization Oven at 45C for 16 hours at 60 RPM. Washing was done using a GeneChip Fluidics Station 450 according to the manufacturer’s instructions, using the buffers provided in the Affymetrix GeneChip Hybridization, Wash and Stain Kit.
|
Scan protocol |
Images were extracted with Affymetrix GeneChip Command Console (AGCC), and analyzed using GeneChip Expression Console. A Primeview CDF that included probe information for the ERCC controls (GPL16043), provided by Affymetrix, was used to generate .CEL files.
|
Data processing |
A CDF provided by Affymetrix, which contained the ERCC probes (PrimeView_withERCC_binary.cdf) was used instead of the standard PrimeView cdf. The data were analyzed with Bioconductor using the MAS5 normalization method. Then, these data were renormalized per batch (B1/B2) to the external spike-ins. See Loven, Orlando et al., Cell, 2012 for additional details.
|
|
|
Submission date |
May 18, 2016 |
Last update date |
Aug 29, 2016 |
Contact name |
Richard A Young |
E-mail(s) |
young_computation@wi.mit.edu
|
Phone |
617-258-5219
|
Organization name |
Whitehead Institute for Biomedical Research
|
Lab |
Young Lab
|
Street address |
9 Cambridge Center
|
City |
Cambridge |
State/province |
MA |
ZIP/Postal code |
02142 |
Country |
USA |
|
|
Platform ID |
GPL16043 |
Series (1) |
GSE72022 |
Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors [Affymetrix] |
|